Kevin Waters is EVP, CFO of PROCEPT BioRobotics Corp. Currently has a direct ownership of 96,096 shares of PRCT, which is worth approximately $7.8 Million. The most recent transaction as insider was on Mar 16, 2023, when has been sold 706 shares (Common Stock) at a price of $31.84 per share, resulting in proceeds of $22,479. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.1K
0% 3M change
186.66% 12M change
Total Value Held $7.8 Million

Kevin Waters Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2023
SELL
Open market or private sale
$22,479 $31.84 p/Share
706 Reduced 1.24%
56,154 Common Stock
Mar 08 2023
SELL
Open market or private sale
$757,500 $34.36 p/Share
22,046 Reduced 27.65%
57,678 Common Stock
Mar 07 2023
SELL
Open market or private sale
$275,685 $34.66 p/Share
7,954 Reduced 12.27%
56,860 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
26,315 Added 23.25%
86,860 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$232,513 $29.38 p/Share
7,914 Added 11.56%
60,545 Common Stock
KW

Kevin Waters

EVP, CFO
Redwood City, CA

Track Institutional and Insider Activities on PRCT

Follow PROCEPT BioRobotics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT